L. Jacob, A. Gowda, S. Kumar et al.
Journal of Molecular Liquids 320 (2020) 114419
29.55, 29.43, 29.39, 28.84, 28.70, 28.63, 28.25, 26.22, 26.18, 22.70, 22.55,
14.11, 14.04 ppm; elemental analysis: C80H132N2O4S2, calculated: C,
76.87; H, 10.64; N, 2.24; S, 5.13, % found: C, 76.77; H, 10.56; N, 2.31; S,
4.91. 1H and 13C NMR spectra are shown in the ESI, Fig. S15.
106.05, 96.12, 87.13, 69.51, 69.08, 67.84, 31.95, 31.26, 29.78, 29.72,
29.60, 29.41, 26.24, 26.21, 22.70, 19.25, 14.11, 13.85 ppm; elemental
analysis: C80H119N2BrO5, calculated: C, 75.73; H, 9.45; N,2.21. % Found:
C, 75.66; H, 9.36, 2.29. 1H and 13C NMR spectra are shown in the ESI,
Fig. S18.
4.4.2. 2,3,6,7-Tetrakis(dodecyloxy)-11,12-bis(octylthio)dibenzo[a,c]phen-
azine (6b)
4.5.2. 11-Bromo-2,3,6,7-tetrakis(dodecyloxy)-12-((4-(octyloxy)phenyl)
ethynyl)dibenzo[a,c]phenazine (7b)
IR (film) υmax: 2953, 2920, 2852, 1608, 1504, 1462, 1377, 1271,
1166, 767 cm−1; 1H NMR (500 MHz, CDCl3): δ = 8.65 (s, 2H), 7.92 (s,
2H), 2 (s, 2H), 4.27 (br, 4H), 4.19 (br, 4H), 3.13 (t, J = 7 Hz, 4H), 1.89
(br, 8H), 1.79–1.20 ppm (m, 96H), 0.80 (m, 18H); 13C NMR (125 MHz,
CDCl3): δ = 151.61, 149.46, 141.17, 140.23, 140.07, 126.35, 124.34,
123.92, 108.56, 106.53, 69.66, 69.17, 33.45, 31.94, 31.82, 30.91, 29.75,
29.69, 29.54, 29.42, 29.3929.20, 29.19, 29.17, 28.29, 26.21, 26.18,
22.69, 14.11, 14.09 ppm; elemental analysis: C84H140N2O4S2, calculated:
C, 77.24; H, 10.80; N, 2.14; S, 4.91, % Found: C, 77.34; H, 10.96; N, 2.23; S,
5.06. 1H and 13C NMR spectra are shown in the ESI, Fig. S16.
IR (film) υmax: 2953, 2922, 2852, 2210, 1606, 1511, 1456, 1375,
1271, 1166, 771, 721 cm−1; 1H NMR (500 MHz, CDCl3): 8.38–8.33 (m,
3H), 8.22 (s, 1H), 7.58 (d, J = 7 Hz, 2H), 7.37 (br, 2H), 6.91 (d, J =
7 Hz, 2H), 4.21 (br, 8H), 3.99 (br, 2H), 1.96 (br, 8H), 1.81–1.28 (m,
84H), 0.86 ppm (br, 15H); 13C NMR (125 MHz, CDCl3): δ = 159.80,
151.89, 151.78, 149.15, 149.10, 142.16, 141.87, 140.95, 139.82, 133.35,
132.65, 131.92, 126.57, 126.38, 125.71, 124.82, 123.13, 123.03, 114.73,
114.68, 108.48, 105.81, 105.68, 87.17, 69.42, 69.38, 69.03, 68.17, 31.96,
31.84, 29.80, 29.74, 29.71, 29.65, 29.43, 29.26, 29.24, 26.27, 26.23,
26.06, 22.71, 22.68, 14.12 ppm; elemental analysis: C84H127N2BrO5,
calculated: C, 76.15; H, 9.66; N, 2.11. % Found: C, 76.26; H, 9.78, N,
2.23. 1H and 13C NMR spectra are shown in the ESI, Fig. S19.
4.4.3. 2,3,6,7-Tetrakis(dodecyloxy)-11,12-bis(dodecylthio)dibenzo[a,c]
phenazine (6c)
IR (film) υmax: 2953, 2918, 2850, 1608, 1510, 1462, 1377, 1271,
1166, 1074, 721 cm−1 1H NMR (500 MHz, CDCl3): δ = 8.67 (s, 2H),
;
4.5.3. 11-Bromo-2,3,6,7-tetrakis(dodecyloxy)-12-((4-(tetradecyloxy)phe-
nyl) ethynyl)dibenzo[a,c]phenazine (7c)
7.94 (s, 2H), 7.67 (s, 2H), 4.28 (br, 4H), 4.20 (br, 4H), 3.14 (t, J =
6.5 Hz, 4H), 1.89 (br, 8H), 1.81–1.19 (m, 112H), 0.80 ppm (br, 18H);
13C NMR (125 MHz, CDCl3): δ = 151.85, 151.60, 149.27, 141.83,
141.25, 140.58, 139.47, 132.06, 131.22, 130.39, 126.66, 126.16, 123.49,
108.59, 106.08, 69.52, 69.12, 69.03, 33.17, 29.78, 29.61, 29.41, 27.85,
22.71, 14.11 ppm; elemental analysis: C92H156N2O4S2, calculated: C,
77.91; H, 11.09; N, 1.98; S, 4.52, % Found: C, 77.79; H, 11.25; N, 2.18; S,
4.65. 1H and 13C NMR spectra are shown in the ESI, Fig. S17.
IR (film) υmax: 2953, 2920, 2866, 2216, 1606, 1506, 1456, 1377,
1271, 1168, 771, 721 cm−1; 1H NMR (500 MHz, CDCl3): 8.53–8.49 (br,
2H), 8.43 (s, 1H), 8.34 (s, 1H), 7.58 (d, J = 8 Hz, 2H), 7.51 (Br, 2H),
6.92 (d, J = 8 Hz, 2H), 4.25 (br, 8H), 3.99 (t, J = 6 Hz, 2H), 2.01–1.93
(m, 8H), 1.84–1.27 (m, 96H), 0.88 ppm (t, J = 6.5 Hz, 15H); 13C NMR
(125 MHz, CDCl3): δ = 159.82, 152, 151.89, 149.25, 142.04, 141.07,
139.95, 133.36, 132.68, 131.98, 126.70, 126.50, 125.88, 124.98, 123.27,
123.19, 114.68, 114.68, 108.57, 106.06, 96.13, 87.13, 69.48, 69.07,
68.18, 31.95, 29.78, 29.72, 29.61, 29.41, 29.37, 29.23, 26.24, 26.05,
22.70, 14.11 ppm; elemental analysis: C90H139N2BrO5, calculated: C,
4.5. Synthesis of symmetrical and unsymmetrical dibenzophenazine based
discotic mesogen (7a–7d and 8a–8c)
76.72; H, 9.94; N,1.99. % Found: C, 76.84; H, 10.10; N, 2.13. 1H and 13
NMR spectra are shown in the ESI, Fig. S20.
C
All the final discotic mesogens were obtained by Sonogashira
C\\C bond coupling reaction between 11,12-dibromo-2,3,6,7-
tetrakis(dodecyloxy)dibenzo[a,c]phenazine (5) with 1-ethynyl-4-
alkoxybenzene in the presence of PdCl2(PPh3)2 and CuI in anhydrous
triethylamine solvent [57,58]. The general method is described as
follows.
4.5.4.
2,3,6,7-tetrakis(dodecyloxy)dibenzo[a,c]phenazine (7d)
IR (film) υmax: 2951, 2922, 2852, 2210, 1608, 1506, 1456, 1375,
1271, 1168, 771, 721 cm−1 1H NMR (500 MHz, CDCl3): 8.40 (s, 1H),
11-Bromo-12-((4-((3,7-dimethyloctyl)oxy)phenyl)ethynyl)-
;
To a mixture of bis(triphenylphosphine) palladium dichloride
(0.04 eq.) and CuI (0.06 eq.) was added compound 5 (0.5 g, 1 eq.) in an-
hydrous triethylamine solvent under nitrogen atmosphere and allowed
to stir at room temperature for 10 min. To the above reaction mixture, 1-
ethynyl-4-(alkoxy)benzene (1.2 eq.) in anhydrous triethylamine was
added under nitrogen flow. The resulting reaction mixture was heating
to 75 °C for 24 h. The residue was diluted with diethyl ether and filtered
through celite pad. The filtrate was washed with water and then ex-
tracted with diethyl ether (3 × 40 mL). The combined extracts were
dried over Na2SO4 and concentrated under reduced pressure. The
crude compound was purified by column chromatography using silica
gel (hexane: ethylacetate 8:2) gives desired compound 7a–7d. Simi-
larly, symmetrical discotic mesogens (8a–8c) were obtained by using
compound 5 (0.5 g, 1 eq.), PdCl2(PPh3)2 (0.08 eq.), CuI (0.09 eq.) and
1-ethynyl-4-(alkoxy)benzene (2.5 eq.) respectively.
8.37 (s, 1H), 8.31 (s, 1H), 8.23 (s, 1H), 7.51 (d, J = 7.5 Hz, 2H), 7.38
(br, 2H), 6.85 (d, J = 7.5 Hz, 2H), 4.16 (m, 8H), 3.97 (br, 2H), 1.90 (m,
8H), 1.8–1.2 (m, 82H), 0.90 (d, J = 6 Hz, 3H), 0.81 ppm (br, 18H); 13
C
NMR (125 MHz, CDCl3): δ = 159.80, 151.98, 151.87, 149.26, 149.22,
142.30, 142.01, 141.06, 139.93, 133.36, 132.69, 131.98, 126.68, 126.48,
125.85, 124.94, 126.26, 123.16, 114.69, 108.58, 106, 105.89, 96.11,
87.14, 69.49, 69.45, 69.07, 66.51, 39.27, 37.33, 36.15, 31.96, 29.90,
29.78, 29.75, 29.72, 29.62, 29.41, 27.99, 26.25, 26.21, 24.68, 22.71,
22.61, 19.67, 14.11 ppm; elemental analysis: C86H131N2BrO5, calculated:
C, 76.35; H, 9.76; N,2.07. % Found: C, 76.25; H, 9.64; N, 1.98. 1H and 13
NMR spectra are shown in the ESI, Fig. S21.
C
4.5.5. 11,12-Bis((4-butoxyphenyl)ethynyl)-2,3,6,7-tetrakis(dodecyloxy)
dibenzo[a,c]phenazine (8a)
IR (film) υmax: 2955, 2922, 2852, 2216, 1606, 1506, 1456, 1377,
1269, 1168, 771, 721 cm−1; 1H NMR (500 MHz, CDCl3): 8.62 (br, 2H),
8.39 (br, 2H), 7.59 (m, 6H), 6.93 (d, J = 8 Hz, 4H), 4.32–4.26 (m, 8H),
4.03 (t, J = 6.5 Hz, 4H), 1.99 (t, J = 6 Hz, 8H), 1.83–1.30 (m, 80H),
1.03 (t, J = 7 Hz, 6H), 0.89 ppm (br, 12H); 13C NMR (125 MHz,
CDCl3): δ = 159.61, 151.88, 149.36, 142.23, 140.73, 133.34, 131.85,
126.57, 125.83, 123.59, 115.15, 114.65, 108.69, 106.23, 95.39, 87.20,
69.57, 69.10, 67.83, 31.94, 31.28, 29.77, 29.71, 29.58, 29.40, 26.20,
22.70, 19.25, 14.11, 13.85 ppm; elemental analysis: C92H132N2O6, calcu-
lated: C, 81.13; H, 9.77; N,2.06. % Found: C, 81.26; H, 9.86; N, 2.18. 1H and
13C NMR spectra are shown in the ESI, Fig. S22.
4.5.1.
11-Bromo-12-((4-butoxyphenyl)ethynyl)-2,3,6,7-tetrakis
(dodecyloxy)dibenzo[a,c]phenazine (7a)
IR (film) υmax: 2951, 2924, 2852, 2214, 1606, 1510, 1454, 1377,
1273, 1166, 773, 721 cm−1 1H NMR (500 MHz, CDCl3): δ = 8.52 (s,
;
1H), 8.49 (s, 1H), 8.43 (s, 1H), 8.34 (s, 1H), 7.61 (d, J = 8 Hz, 2H), 7.50
(br, 2H), 6.95 (d, J = 8 Hz, 2H), 4.29–4.24 (br, 8H), 4.03 (t, J = 5.5 Hz,
2H), 2.0 (br, 8H), 1.83–1.30 (m, 76H), 1.03 (t, J = 6.5 Hz, 3H),
0.98 ppm (br, 12H); 13C NMR (125 MHz, CDCl3): δ = 159.82, 152,
151.89, 149.29, 149.25, 142.33, 142.04, 141.07, 139.95, 133.36, 132.70,
131.99, 126.70, 126.51, 125.88, 124.97, 123.28, 123.19, 114.68, 108.61,
8